Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although cellular senescence may be a protective mechanism in modulating proliferative capacity, fibroblast senescence is now recognized as a key pathogenic mechanism in idiopathic pulmonary fibrosis (IPF). In aged mice, abundance and persistence of apoptosis-resistant senescent fibroblasts play a central role in nonresolving lung fibrosis after bleomycin challenge. Therefore, we investigated whether quercetin can restore the susceptibility of senescent IPF fibroblasts to proapoptotic stimuli and mitigate bleomycin-induced pulmonary fibrosis in aged mice. Unlike senescent normal lung fibroblasts, IPF lung fibroblasts from patients with stable and rapidly progressing disease were highly resistant to Fas ligand (FasL)-induced and TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Senescent IPF fibroblasts exhibited decreased expression of FasL and TRAIL receptors and caveolin-1, as well as increased AKT activation, compared with senescent normal lung fibroblasts. Although quercetin alone was not proapoptotic, it abolished the resistance to FasL- or TRAIL-induced apoptosis in IPF fibroblasts. Mechanistically, quercetin upregulated FasL receptor and caveolin-1 expression and modulated AKT activation. In vivo quercetin reversed bleomycin-induced pulmonary fibrosis and attenuated lethality, weight loss, and the expression of pulmonary senescence markers p21 and p19-ARF and senescence-associated secretory phenotype in aged mice. Collectively, these data indicate that quercetin reverses the resistance to death ligand-induced apoptosis by promoting FasL receptor and caveolin-1 expression and inhibiting AKT activation, thus mitigating the progression of established pulmonary fibrosis in aged mice. Therefore, quercetin may be a viable therapeutic option for IPF and other age-related diseases that progress with the accumulation of senescent fibroblasts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Preclinical evidence suggests that senescent fibroblasts and alveolar epithelial cells contribute to pulmonary fibrosis and supports cellular senescence as a potential target for treatment for bleomycin-induced lung injury model of pulmonary fibrosis that may be translationally relevant to humans.5,10,11”
From Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability (2023) · cites this paper as [10]
Experimental — accuracy not yet measuredIn the citing paper
“In bleomycin-induced pulmonary fibrosis models, monotherapy with quercetin markedly reduced senescent markers.10”
In the citing paper
“Augmentation of endogenous Cav-1 levels and supplementation of exogenous caveolin scaffolding domain (CSD) peptide have been shown to suppress lung fibrosis7,10,11,13,14.”
From Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study (2026) · cites this paper as [13]
Citations
Cites
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,258
Health effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805
PI 3-kinase, Akt and cell survival
Downward, J. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.01.002 · Cited by 783
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686
The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis
Martinez, F. J., Safrin, S., Weycker, D., Starko, K. M., Bradford, W. Z., King, T. E., Flaherty, K. R., Schwartz, D. A., Noble, P. W., Raghu, G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00005 · Cited by 622
Martinez-Outschoorn, U. E., Balliet, R. M., Rivadeneira, D., Chiavarina, B., Pavlides, S., Wang, C., Whitaker-Menezes, D., Daumer, K., Lin, Z., Witkiewicz, A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12553 · Cited by 460
Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02367-2016 · Cited by 403
Minagawa, S., Araya, J., Numata, T., Nojiri, S., Hara, H., Yumino, Y., Kawaishi, M., Odaka, M., Morikawa, T., Nishimura, S. L., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00097.2010 · Cited by 323
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Guignabert, C., Phan, C., Seferian, A., Huertas, A., Tu, L., Thuillet, R., Sattler, C., Le Hiress, M., Tamura, Y., Jutant, E.-M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86249 · Cited by 276
Zhang, X. D., Nguyen, T., Thomas, W. D., Sanders, J. E., & Hersey, P. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02042-1 · Cited by 218
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis
Pardo, A., & Selman, M. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-341aw · Cited by 204
Strategies targeting cellular senescence
Ovadya, Y., & Krizhanovsky, V. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95149 · Cited by 200
Blue Journal Conference. Aging and Susceptibility to Lung Disease
Thannickal, V. J., Murthy, M., Balch, W. E., Chandel, N. S., Meiners, S., Eickelberg, O., Selman, M., Pardo, A., White, E. S., Levy, B. D., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1876pp · Cited by 166
Elimination of p19ARF-expressing cells enhances pulmonary function in mice
Hashimoto, M., Asai, A., Kawagishi, H., Mikawa, R., Iwashita, Y., Kanayama, K., Sugimoto, K., Sato, T., Maruyama, M., & Sugimoto, M. (2016) · JCI Insight · doi:10.1172/jci.insight.87732 · Cited by 162
TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis
Trujillo, G., Meneghin, A., Flaherty, K. R., Sholl, L. M., Myers, J. L., Kazerooni, E. A., Gross, B. H., Oak, S. R., Coelho, A. L., Evanoff, H., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001510 · Cited by 160
Self-citationPathologic Caveolin-1 Regulation of PTEN in Idiopathic Pulmonary Fibrosis
Hong, X., Khalil, W., Kahm, J., Jessurun, J., Kleidon, J., & Henke, C. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091117 · Cited by 159
Huang, S. K., Scruggs, A. M., Donaghy, J., Horowitz, J. C., Zaslona, Z., Przybranowski, S., White, E. S., & Peters-Golden, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.146 · Cited by 147
Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation
Liu, J., Lee, P., Galbiati, F., Kitsis, R. N., & Lisanti, M. P. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c823 · Cited by 139
Dagouassat, M., Gagliolo, J.-M., Chrusciel, S., Bourin, M.-C., Duprez, C., Caramelle, P., Boyer, L., Hue, S., Stern, J.-B., Validire, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1361oc · Cited by 120
The emerging role of senescent cells in tissue homeostasis and pathophysiology
Tominaga, K. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.27743 · Cited by 113
Steegmann, J. L., Cervantes, F., le Coutre, P., Porkka, K., & Saglio, G. (2012) · Leukemia & Lymphoma · doi:10.3109/10428194.2012.695779 · Cited by 113
Dasatinib in chronic myeloid leukemia: a review
Tsimberidou, A.-M. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3425 · Cited by 101
Nho, R. S., Peterson, M., Hergert, P., & Henke, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061017 · Cited by 82
Huang, W.-T., Akhter, H., Jiang, C., MacEwen, M., Ding, Q., Antony, V., Thannickal, V. J., & Liu, R.-M. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.11.018 · Cited by 80
Bühling, F., Wille, A., Röcken, C., Wiesner, O., Baier, A., Meinecke, I., Welte, T., & Pap, T. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-37 · Cited by 75
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis
Habiel, D. M., & Hogaboam, C. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00002 · Cited by 75
Self-citationTelomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential
Adnot, S., Amsellem, V., Boyer, L., Marcos, É., Saker, M., Houssaini, A., Kebe, K., Dagouassat, M., Lipskaia, L., & Boczkowski, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.007 · Cited by 72
Jacquemin, G., Shirley, S., & Micheau, O. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0407-6 · Cited by 70
Russo, M., Palumbo, R., Mupo, A., Tosto, M., Iacomino, G., Scognamiglio, A., Tedesco, I., Galano, G., & Russo, G. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206493 · Cited by 69
Wynes, M. W., Edelman, B. L., Kostyk, A. G., Edwards, M. G., Coldren, C., Groshong, S. D., Cosgrove, G. P., Redente, E. F., Bamberg, A., Brown, K. K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100447 · Cited by 68
Sundar, I. K., Rashid, K., Gerloff, J., Li, D., & Rahman, I. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0390oc · Cited by 53
Direct Tracheal Instillation of Solutes into Mouse Lung
Helms, M. N., Torres-González, E., Goodson, P., & Rojas, M. (2010) · Journal of Visualized Experiments · doi:10.3791/1941 · Cited by 49
Mougeolle, A., Poussard, S., Décossas, M., Lamaze, C., Lambert, O., & Dargelos, É. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122654 · Cited by 48
McGrath, E. E., Lawrie, A., Marriott, H. M., Mercer, P. F., Cross, S. S., Arnold, N. D., Singleton, V., Thompson, A. A. R., Walmsley, S. R., Renshaw, S. A., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200863 · Cited by 39
Pulmonary Hypertension in Parenchymal Lung Diseases
Harari, S. A., Elia, D., & Humbert, M. J. C. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.06.008 · Cited by 39
Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts
Sanders, Y. Y., Liu, H., Scruggs, A. M., Duncan, S. R., Huang, S. K., & Thannickal, V. J. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0034oc · Cited by 38
Cutting edge: FasL+ immune cells promote resolution of fibrosis
Wallach‐Dayan, S. B., Elkayam, L., Golan‐Gerstl, R., Konikov-Rozenman, J., Zisman, P., Richter-Dayan, M., Arish, N., & Breuer, R. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.02.006 · Cited by 34
Licence to kill senescent cells in idiopathic pulmonary fibrosis?
Mailleux, A., & Crestani, B. (2017) · European Respiratory Journal · doi:10.1183/13993003.01360-2017 · Cited by 21
TRAIL-Dependent Resolution of Pulmonary Fibrosis
Habiel, D. M., Serezani, A. P. M., Ismailoglu, U. B., Dunleavy, M. P., Cavassani, K. A., van Rooijen, N., Coelho, A. L., & Hogaboam, C. M. (2018) · Mediators of Inflammation · doi:10.1155/2018/7934362 · Cited by 15
Self-citation
Research works printed but not linked: 1
- Pechkovsky, 2012, Fibroblast senescence in UIP/IPF: a contributing factor or consequence of the disease? [abstract], Am J Respir Crit Care Med, 185, A5282
Cited by
Wound healing: cellular mechanisms and pathological outcomes
Wilkinson, H. N., & Hardman, M. J. (2020) · Open Biology · doi:10.1098/rsob.200223 · Cited by 1,796
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases
Barnes, P. J., Baker, J., & Donnelly, L. E. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1975tr · Cited by 555
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Wang, J., Hu, K., Cai, X., Yang, B., He, Q., Wang, J., & Weng, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.023 · Cited by 450
Metadata
- Authors
- Hohmann, M. S., Habiel, D. M., Coelho, A. L., Verri, W. A., & Hogaboam, C. M.
- Affiliations
- Universidade Estadual de Londrina (BR)
- Cedars-Sinai Medical Center (US)
- Departmento de Ciências Patológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brasil; and
- Corresponding author
- Hogaboam, Cory M.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-01
- Volume
- 60
- Issue
- 1
- Pages
- 28-40
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC6348716
- OpenAlex
- W2885632389
- Cited by
- 202
- References
- 46
- Citations by year
- 2026: 17 · 2025: 28 · 2024: 32 · 2023: 39 · 2022: 27 · 2021: 19 · 2020: 24 · 2019: 13
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- National Institutes of Health (NIH-R01, R01‐grant, HL123899)
- National Heart, Lung, and Blood Institute (R01HL123899)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- quercetin, idiopathic pulmonary fibrosis, cellular senescence, fibroblast senescence, apoptosis resistance, Fas ligand, TRAIL, caveolin-1, Akt activation, senescence-associated secretory phenotype, bleomycin-induced lung fibrosis, aged mice, p21, antifibrotic therapy
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Antioxidants, Bleomycin, Female, Fibroblasts, Humans, Male, Mice, Inbred C57BL, Quercetin, Cellular Senescence, Apoptosis, Mice, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.